Liberal and Labor vow to maintain intravitreal injection MBS rebate
Macular Disease Foundation Australia (MDFA) has had an undertaking by both major political parties that they won’t implement an MBS ...
Macular Disease Foundation Australia (MDFA) has had an undertaking by both major political parties that they won’t implement an MBS ...
Key ophthalmic organisations have revealed their federal election wish lists, drawing attention to issues such as workforce maldistribution and access ...
New Medicare items have been introduced allowing allied health professionals, including optometrists and orthoptists, to be reimbursed for participating in ...
The Federal Government and the Australian Medical Association (AMA) have agreed to co-design administrative processes for implementing upcoming changes to ...
With optometrists performing three-quarters of all eye exams in Australia, the optometric Medicare schedule has a major bearing on the ...
Advances in glaucoma stent technology far outstripped the Medicare schedule early on, creating a disconnect that had far-reaching consequences. As ...
Nova Eye Medical has announced an application to secure public funding for its iTrack ab-interno canaloplasty as a standalone minimally ...
The head of ophthalmic surgery at a major public hospital says the current Medicare fee for intravitreal injections only creates ...
Nova Eye Medical is seeking a modification to the existing minimally invasive glaucoma surgery (MIGS) Medicare item number that only ...
A snapshot of medico-legal matters against ophthalmologists insured by an Australian medical defence organisation has found claims for compensation and ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited